[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
January 1995

Confluent and Reticulated Papillomatosis of Gougerot and Carteaud: Minocycline Deserves Trial Before Etretinate

Arch Dermatol. 1995;131(1):109-110. doi:10.1001/archderm.1995.01690130113028
Abstract

Baalbaki et al1 reported the temporal response of confluent and reticulated papillomatosis to etretinate (0.25 to 0.4 mg/kg per day for 1 month) in five adult men who had been previously treated with ketoconazole without success. No mention was made in their article about minocycline treatment,2,3 which is a therapeutic alternative possibly safer than ketoconazole and etretinate as regards potential hepatotoxicity and teratogenicity in women of child-bearing age. This prompts us to report a case of confluent papillomatosis in a young woman who responded to minocycline treatment.

Report of a Case.  A 20-year-old white woman presented with a hyperpigmented reticulated eruption that had appeared 5 years before, had extended slowly, and had remained stable for the last 2 years. Apart from minimal atopic dermatitis, her medical history was unremarkable. She denied intake of any oral medication or drug abuse. Physical examination disclosed hyperpigmented nondesquamative reticulated macules on the

First Page Preview View Large
First page PDF preview
First page PDF preview
×